Matthew Hall to Enzyme Inhibitors
This is a "connection" page, showing publications Matthew Hall has written about Enzyme Inhibitors.
Connection Strength
0.917
-
High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2. J Biol Chem. 2018 08 31; 293(35):13750-13765.
Score: 0.339
-
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays. Sci Rep. 2017 10 06; 7(1):12758.
Score: 0.322
-
Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma. Cancer Res. 2019 10 01; 79(19):5060-5073.
Score: 0.092
-
Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors. Bioorg Med Chem. 2018 05 01; 26(8):1727-1739.
Score: 0.083
-
Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH). J Med Chem. 2017 11 22; 60(22):9184-9204.
Score: 0.081